Goldman Sachs’s Zymergen Inc. Common Stock ZY Stock Holding History

Goldman Sachs’s Portfolio ZY Stock Details ZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-178,782	Closed	-$497K	–	6623
2022 Q3	$497K	Sell	178,782 -28,423	-14%	-$69K	﹤0.01%	4979
2022 Q2	$255K	Sell	207,205 -31,243	-13%	-$52.4K	﹤0.01%	5513
2022 Q1	$688K	Sell	238,448 -2,105	-0.9%	-$8.94K	﹤0.01%	5119
2021 Q4	$1.61M	Buy	240,553 +63,913	+36%	+$621K	﹤0.01%	4432
2021 Q3	$2.33M	Sell	176,640 -336,163	-66%	-$7.13M	﹤0.01%	4052
2021 Q2	$20.5M	Buy	+512,803	New	+$20.2M	﹤0.01%	2033

Goldman Sachs's ZY Position: Q4 2022 in Review

Goldman Sachs sold out of Zymergen Inc. Common Stock (ZY) in Q4 2022, closing a stake of 178,782 shares — an estimated $497K sold.

Goldman Sachs first reported a position in ZY in Q2 2021 and held it in 6 quarters. The position peaked at $20.5M in Q2 2021. 0 funds tracked by Wall St. Rank hold ZY as of Q4 2022.

Goldman Sachs reported no remaining Zymergen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Goldman Sachs sold 178,782 Zymergen Inc. Common Stock shares in Q4 2022, an estimated $497K.
Goldman Sachs first reported a position in Zymergen Inc. Common Stock in Q2 2021 and held it in 6 quarters.
Goldman Sachs's Zymergen Inc. Common Stock position peaked at $20.5M in Q2 2021.
0 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2022.

Based on Goldman Sachs's 13F filing for Q4 2022, filed 13 Feb 2023.